Hongli Zhou

1.3k total citations
41 papers, 831 citations indexed

About

Hongli Zhou is a scholar working on Molecular Biology, Infectious Diseases and Cancer Research. According to data from OpenAlex, Hongli Zhou has authored 41 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 7 papers in Infectious Diseases and 7 papers in Cancer Research. Recurrent topics in Hongli Zhou's work include Gut microbiota and health (8 papers), MicroRNA in disease regulation (5 papers) and Viral gastroenteritis research and epidemiology (5 papers). Hongli Zhou is often cited by papers focused on Gut microbiota and health (8 papers), MicroRNA in disease regulation (5 papers) and Viral gastroenteritis research and epidemiology (5 papers). Hongli Zhou collaborates with scholars based in China, United States and France. Hongli Zhou's co-authors include Xiaobin Wang, Jianguo Feng, Li Liu, Bo Huang, Zhiyue Lv, Miaomiao Lu, Tianmei Li, Chunxiang Zhang, Jing Mao and Yu‐Bin Ma and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Hongli Zhou

40 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongli Zhou China 19 337 150 120 92 87 41 831
Angelica Perna Italy 22 343 1.0× 151 1.0× 129 1.1× 104 1.1× 45 0.5× 63 1.1k
Cecilia Castro United Kingdom 20 459 1.4× 94 0.6× 80 0.7× 64 0.7× 105 1.2× 32 908
Sumei Zhang China 19 408 1.2× 92 0.6× 111 0.9× 147 1.6× 153 1.8× 70 1.1k
Shuhua Li China 18 264 0.8× 113 0.8× 71 0.6× 45 0.5× 52 0.6× 57 984
Arthur Wang United States 19 390 1.2× 191 1.3× 126 1.1× 157 1.7× 29 0.3× 52 1.2k
Christina Pettan-Brewer United States 16 314 0.9× 65 0.4× 90 0.8× 33 0.4× 84 1.0× 47 868
Yoon Jung South Korea 15 307 0.9× 157 1.0× 64 0.5× 105 1.1× 52 0.6× 43 952

Countries citing papers authored by Hongli Zhou

Since Specialization
Citations

This map shows the geographic impact of Hongli Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongli Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongli Zhou more than expected).

Fields of papers citing papers by Hongli Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongli Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongli Zhou. The network helps show where Hongli Zhou may publish in the future.

Co-authorship network of co-authors of Hongli Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Hongli Zhou. A scholar is included among the top collaborators of Hongli Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongli Zhou. Hongli Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Haibin, et al.. (2024). Correction to: Natural compounds modulate the mechanism of action of tumour-associated macrophages against colorectal cancer: a review. Journal of Cancer Research and Clinical Oncology. 151(1). 26–26. 1 indexed citations
3.
Wang, Feng, Fumei Wang, Yang Xia, et al.. (2024). A dynamic online nomogram for predicting renal outcomes of idiopathic membranous nephropathy. BMC Medical Informatics and Decision Making. 24(1). 173–173. 3 indexed citations
4.
Zhou, Hongli, Hongli Zhou, Haibin Chen, et al.. (2023). Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application. Biomedicine & Pharmacotherapy. 165. 115040–115040. 19 indexed citations
5.
Qiu, Wenli, et al.. (2023). Integrated gut microbiota and metabolome analysis reveals the mechanism of Xiaoai Jiedu recipe in ameliorating colorectal cancer. Frontiers in Oncology. 13. 1184786–1184786. 5 indexed citations
6.
Liang, Xiaofei, Hongli Zhou, Jia‐Lun Duan, et al.. (2023). Integrated gut microbiota and fecal metabolome analyses of the effect ofLycium barbarumpolysaccharide ond-galactose-induced premature ovarian insufficiency. Food & Function. 14(15). 7209–7221. 28 indexed citations
7.
Liu, Wenlin, et al.. (2023). Fluorofenidone Attenuates Renal Interstitial Fibrosis by Enhancing Autophagy and Retaining Mitochondrial Function. Cell Biochemistry and Biophysics. 81(4). 777–785. 4 indexed citations
8.
Chen, Haibin, Ying Yuan, Hongli Zhou, et al.. (2023). A bibliometric and visual analysis of cancer-associated fibroblasts. Frontiers in Immunology. 14. 1323115–1323115. 17 indexed citations
9.
Qiu, Wenli, et al.. (2022). Wenzi Jiedu Recipe ameliorates colorectal cancer by remodeling the gut microbiota and tumor microenvironment. Frontiers in Oncology. 12. 915498–915498. 10 indexed citations
10.
Chen, Dongni, Hongli Zhou, Kaican Cai, et al.. (2022). CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling. Journal of Experimental & Clinical Cancer Research. 41(1). 120–120. 26 indexed citations
11.
Qiu, Wenli, et al.. (2020). The Relationship between Prevention and Treatment of Colorectal Cancer and Cancerous Toxin Pathogenesis Theory Basing on Gut Microbiota. Evidence-based Complementary and Alternative Medicine. 2020(1). 7162545–7162545. 9 indexed citations
12.
Mao, Jing, Tianmei Li, Hongli Zhou, et al.. (2020). Abnormal expression of rno_circRNA_014900 and rno_circRNA_005442 induced by ketamine in the rat hippocampus. BMC Psychiatry. 20(1). 1–1. 87 indexed citations
13.
Hu, Yue, Ping Huang, Hongli Zhou, et al.. (2019). Taxonomic integrative and phylogenetic identification of the first recorded Triatoma rubrofasciata in Zhangzhou, Fujian Province and Maoming, Guangdong Province, China. Infectious Diseases of Poverty. 8(1). 70–70. 8 indexed citations
14.
Yan, Hui, et al.. (2017). Resveratrol improves mitochondrial function in the remnant kidney from 5/6 nephrectomized rats. Acta Histochemica. 119(4). 392–399. 35 indexed citations
15.
Zhang, Yang, Zhichao Yang, Sen Zhao, & Hongli Zhou. (2016). A Phenolic Ester of <i>O</i>-Desmethylvenlafaxine (ODV) Improves Uptake of ODV into the Brain. American journal of biochemistry & biotechnology. 12(4). 263–269. 1 indexed citations
16.
Huang, Bo, et al.. (2016). Effect of silencing SATB1 on proliferation, invasion and apoptosis of A549 human lung adenocarcinoma cells. Oncology Letters. 12(5). 3818–3824. 11 indexed citations
17.
Du, Yuchen, Qiang Guo, Yongmei Wu, et al.. (2016). Spatial and Temporal Distribution of Dopaminergic Neurons during Development in Zebrafish. Frontiers in Neuroanatomy. 10. 115–115. 57 indexed citations
18.
Guo, Li, Xi Zhang, Lili Ren, et al.. (2014). Human Antibody Responses to Avian Influenza A(H7N9) Virus, 2013. Emerging infectious diseases. 20(2). 192–200. 54 indexed citations
19.
Guo, Li, Chengjun Wu, Hongli Zhou, et al.. (2013). Identification of a Nonstructural DNA-Binding Protein (DBP) as an Antigen with Diagnostic Potential for Human Adenovirus. PLoS ONE. 8(3). e56708–e56708. 4 indexed citations
20.
Huang, Bo, et al.. (2013). Silencing SATB1 with siRNA inhibits the proliferation and invasion of small cell lung cancer cells. Cancer Cell International. 13(1). 8–8. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026